This HTML5 document contains 111 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37213893
rdf:type
wikibase:Item
schema:description
bilimsel makale scientific article published on December 1986 article científic наукова стаття, опублікована в грудні 1986 wetenschappelijk artikel مقالة علمية نشرت في ديسمبر 1986 научни чланак videnskabelig artikel articolo scientifico vedecký článok article scientifique vetenskaplig artikel vědecký článek wissenschaftlicher Artikel artigo científico artículu científicu espublizáu en 1986
p:P577
wds:Q37213893-53B79561-30C2-42FA-9911-7FA092C4F9BE
wdt:P577
1986-12-01T00:00:00Z
p:P407
wds:Q37213893-FDC675D7-47D1-4374-814D-4B43D9561915
wdt:P407
wd:Q1860
p:P2860
wds:Q37213893-DF9DFA2B-F4EA-48B6-8B24-BC20E5899C1E wds:Q37213893-E51990CB-3567-4307-B061-157115401538 wds:Q37213893-E781252F-A922-4642-B859-177990826F6E wds:Q37213893-BE83619F-8C6B-4E47-91FD-76A90E4C54A5 wds:Q37213893-C2416721-D48A-465E-A60A-E382792DB876 wds:Q37213893-C5661585-7AF0-48B3-BC60-A3D4C3523A03 wds:Q37213893-FD795F39-8A88-49C8-8ECD-9E337AD506A3 wds:Q37213893-EB43B713-4160-4366-A53C-8EB46B763407 wds:Q37213893-F1391AA1-5F7F-4CC1-AA09-1D3A52A5C7A4 wds:Q37213893-F69EE257-62BE-4E59-921A-D2C3ACA47DD3 wds:Q37213893-F8FCA547-5826-4BA3-A5CF-3F5A42A332C3 wds:Q37213893-74EEE468-B00E-4439-A306-A3DBDD3CEE1F wds:Q37213893-7E40F044-899C-4815-A55E-7A904896E07F wds:Q37213893-56486F6D-CF09-4FFB-85E5-C848C2B6C57E wds:Q37213893-A8E777A1-883E-4D59-8617-AE3E880E3050 wds:Q37213893-BDC0E591-1217-4BAC-BC33-9B768D9AEAE7 wds:Q37213893-BE6A61AF-A952-40D9-86F3-2E410C0925AB wds:Q37213893-8184E6C6-399F-42F3-85D0-C8918831C99D wds:Q37213893-A83CA08A-C2BC-415F-B852-BC3F70037085 wds:Q37213893-06B7DC00-2051-47A9-ABB9-C1CA763BE10B wds:Q37213893-146C8B2B-A4EE-4DDB-8741-E52651E84723 wds:Q37213893-4196D7A9-9A4A-48C5-985D-92C1A781F21E wds:Q37213893-459BBCAA-2F50-4E2C-A61A-8B9C6F2B1452 wds:Q37213893-16588E32-E83C-4A69-855D-751072E3C0F1 wds:Q37213893-1A44D094-5180-419C-94BD-07E027D7A65B wds:Q37213893-1F4CC9C2-C4E3-478A-9E34-4BB81302C920 wds:Q37213893-3578D49C-98A6-49A4-9ADD-C6E4067C27B1
wdt:P2860
wd:Q36444916 wd:Q68609805 wd:Q45228416 wd:Q36906946 wd:Q36907968 wd:Q45797748 wd:Q35242073 wd:Q36251747 wd:Q40139800 wd:Q33658604 wd:Q39458363 wd:Q40107723 wd:Q39898617 wd:Q45844374 wd:Q37401442 wd:Q39393682 wd:Q40256084 wd:Q36423561 wd:Q28131712 wd:Q45803417 wd:Q45091342 wd:Q39320801 wd:Q37110812 wd:Q45797474 wd:Q41998319 wd:Q43654478 wd:Q37198915
p:P2093
wds:Q37213893-E1F548E0-85FF-45B7-9993-2B6B39F23DB3 wds:Q37213893-FC69A8B8-410D-4D27-A8A7-3F156B614522 wds:Q37213893-0DB77F82-7C1E-44B5-9115-DF427622F80C wds:Q37213893-4267DE80-9149-46AD-B883-B3678488C979 wds:Q37213893-637C8A1B-43FC-4210-8C8D-9976BF97F8A0
wdt:P2093
R L Ashley L Corey M L Shurtleff C H Sherlock K D Mack
rdfs:label
Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection
skos:prefLabel
Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection
schema:name
Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection
p:P1476
wds:Q37213893-57C257FA-17C2-4798-9BC4-CB0EF02B9D8D
wdt:P1476
Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection
p:P304
wds:Q37213893-52432D03-110B-4171-ACA0-487FD84C569D
wdt:P304
1093-1097
p:P31
wds:Q37213893-36799DFC-7BF0-4284-B428-998959D4B6B2
wdt:P31
wd:Q13442814
p:P698
wds:Q37213893-A861D35A-76A2-413B-8200-0ECA7A923D11
wdtn:P698
n11:3023439
wdt:P698
3023439
p:P1433
wds:Q37213893-9E27FBE2-C2A6-4E3F-A221-52AAE147E5E1
wdt:P1433
wd:Q4041880
p:P433
wds:Q37213893-5CB30CD2-2B69-4859-A41B-510FCC52927B
p:P478
wds:Q37213893-8FBDFD3D-5B98-4561-AACD-2C53224A9093
wdt:P433
6
wdt:P478
24
p:P932
wds:Q37213893-D51FA29A-48B9-4990-AAE0-800E125CDE0E
wdt:P932
269105